Alex Capano, DNP, CRNP, FNP-BC
Alex Capano, DNP, CRNP, FNP-BC, is the chief science officer at Ecofibre Limited, a global biotech company focused on hemp-derived supplements, food, textiles, and medical devices. Most recently, Dr. Capano published a study on the possibility of using cannabinoids to reduce opioid use in chronic pain patients. Current projects include researching CBD's role in treating chemotherapy-induced neuropathic pain and agitation in dementia patients, as well as identifying industrial applications of hemp-derived cannabinoids. She is also a senior fellow at Thomas Jefferson University and a board certified family nurse practitioner.